Evaluation of hypercalcemia in relation to hyperparathyroidism

Otolaryngologic Clinics of North America

Volumn 43, Issue 2, 2010, Pages 389-397

  Pellitteri, Phillip K ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1,25 Dihydroxyvitamin D; Hypercalcemia; Parathyroid hormone; Primary hyperparathyroidism

Indexed keywords

ALENDRONIC ACID; CALCIMIMETIC AGENT; CALCITRIOL; CALCIUM; CYCLIN D1; LITHIUM SALT; METHIONINE; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; RETINOL; RISEDRONIC ACID; THIAZIDE DIURETIC AGENT; VITAMIN D;

BONE DISEASE; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM DEFICIENCY; CALCIUM EXCRETION; CALCIUM INTAKE; CALCIUM TRANSPORT; CAUSAL ATTRIBUTION; CELL PROLIFERATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG USE; GRANULOMATOSIS; HUMAN; HYPERCALCEMIA; HYPERTHYROIDISM; NEOPLASM; OSTEOCLAST; OSTEOLYSIS; PANCREATITIS; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; PEPTIC ULCER; PREVALENCE; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; VITAMIN D DEFICIENCY; VITAMIN INTAKE;

ADULT; CALCIUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; HYPERPARATHYROIDISM, SECONDARY; PANCREATITIS; PARATHYROID HORMONE; PARATHYROIDECTOMY; PEPTIC ULCER; VITAMIN D;

EID: 77953253653     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2010.02.006     Document Type: Review

References (21)

1. Frolich A. Prevalence of hypercalcemia in normal and hospitalized populations. Dan Med Bull 1998, 45:436-439.
2. Mundy F.R., Guise T.A. Hormonal control of calcium homeostasis. Clin Chem 1999, 45:1347-1352.
3. Brown E.M., Pollak M., Seidman C.E., et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med 1995, 333:234-240.
4. Marx S.J., Attie M.F., Levine M.A., et al. The hypercalciuric or benign variant of familial hypercalcemia: clinical and biochemical features of in fifteen kindreds. Medicine 1981, 60:397-412.
5. Grill V., Ho P., Body J.J., et al. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 1991, 73:1309-1315.
6. Ikeda K., Ohno H., Hane M., et al. Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma. J Clin Endocrinol Metab 1994, 79:1322-1327.
7. Nagai Y., Yamato H., Akogi K., et al. Role of interleukin 6 in uncoupling of bone in vivo in a human squamous carcinoma co-producing PTHrp and interleukin 6. J Bone Miner Res 1998, 13:664-672.
8. Breslau N.A., McGuire J.L., Zerwekh J.E., et al. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 1984, 100:1-7.
9. Rosenthal N.R., Insogna K.L., Godsall J.W., et al. Elevations in circulating 1,25(OH)2D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 1985, 60:29-33.
10. Adams J.S., Fernandez M., Gacad M.A., et al. Vitamin D metabolite mediated hypercalcemia and hypercalciuria in patients with AIDS and non-AIDS-associated lymphoma. Blood 1989, 73:235-239.
11. Seymour J.F., Gagel R.F. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood 1993, 82:1383-1394.
12. Mundy G.R., Yoneda T., Guise T.A. Hypercalcemia in hematologic malignancies and in solid tumors associated with extensive localized bone destruction. Primer on metabolic bone diseases and disorders of mineral metabolism 1999, 183-187. Lippencott Williams and Wilkins, Philadelphia. 4th edition. M.J. Favus (Ed.).
13. Knecht T.P., Behling C.A., Burton D.W., et al. The humoral hypercalcemia of benignancy. A newly appreciated syndrome. Am J Clin Pathol 1996, 105:487-492.
14. Burman K.D., Monchick J.M., Earll J.M., et al. Ionized and total serum calcium and parathyroid hormone in hyperparathyroidism. Ann Intern Med 1976, 84:668-671.
15. Stewart A.F., Hoecker J., Segre G.V., et al. Hypercalcemia in pheochromocytoma: evidence for a novel mechanism. Ann Intern Med 1985, 102:776-779.
16. Mune T., Katakami H., Kato Y., et al. Production and secretion of parathyroid hormone-related protein in pheochromocytoma: participation of an α-adrenergic mechanism. J Clin Endocrinol Metab 1993, 76:757-762.
17. Adams J.S., Singer F.R., Gacad M.A., et al. Isolation and structural identification of 1,25-dihyroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 1985, 60:960-966.
18. Edelson G.W., Talpos G.B., Bone H.G. Hypercalcemia associated with Wegener's granulomatosis and hyperparathyroidism: etiology and management. Am J Nephrol 1993, 13:275-277.
19. Stoeckle J.D., Hardy H.L., Weber A.L. Chronic beryllium disease: long-term follow-up of sixty cases and selective review of the literature. Am J Med 1969, 46:545-561.
20. Parker M.S., Dokoh S., Woolfenden J.M., et al. Hypercalcemia in coccidioidomycosis. Am J Med 1983, 74:721-724.
21. Tominaga Y., Takagi H. Molecular genetics of hyperparathyroidism disease. Curr Opin Nephrol Hypertens 1996, 5:336-341.